"Oesophageal cancer" trang 1 - tải miễn phí từ tailieunhanh
The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: A case control study

The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: A case control study
11    6    1
Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: A case report and review of the literature

Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: A case report and review of the literature
5    65    0
Trends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952–2006: An age-period-cohort analysis

Trends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952–2006: An age-period-cohort analysis
11    45    1
Visceral adipose tissue modulates radiosensitivity in oesophageal adenocarcinoma

Visceral adipose tissue modulates radiosensitivity in oesophageal adenocarcinoma
10    83    0
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: A randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: A randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
11    17    1
The prognostic value of separate lymphatic invasion and vascular invasion in oesophageal squamous cell carcinoma: A meta-analysis and systematic review

The prognostic value of separate lymphatic invasion and vascular invasion in oesophageal squamous cell carcinoma: A meta-analysis and systematic review
12    8    1
Augmenting cancer registry data with health survey data with no cases in common: The relationship between prediagnosis health behaviour and postdiagnosis survival in oesophageal cancer

Augmenting cancer registry data with health survey data with no cases in common: The relationship between prediagnosis health behaviour and postdiagnosis survival in oesophageal cancer
11    46    1
Comparative oesophageal cancer risk assessment of hot beverage consumption (coffee, mate and tea): The margin of exposure of PAH vs very hot temperatures

Comparative oesophageal cancer risk assessment of hot beverage consumption (coffee, mate and tea): The margin of exposure of PAH vs very hot temperatures
13    74    1
Symptoms, problems and quality of life in patients newly diagnosed with oesophageal and gastric cancer – a comparative study of treatment strategy

Symptoms, problems and quality of life in patients newly diagnosed with oesophageal and gastric cancer – a comparative study of treatment strategy
14    19    1
High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08

High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08
9    67    0
Barrett’s oESophagus trial 3 (BEST3): Study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

Barrett’s oESophagus trial 3 (BEST3): Study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux
16    88    0
Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy

Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy
9    75    0
Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro

Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro
10    57    1
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: A stepped-wedge cluster randomised trial

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: A stepped-wedge cluster randomised trial
12    66    1
MiR-193b promotes autophagy and nonapoptotic cell death in oesophageal cancer cells

MiR-193b promotes autophagy and nonapoptotic cell death in oesophageal cancer cells
13    73    1
Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: Predictors of outcome

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: Predictors of outcome
8    40    1
Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence

Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence
10    34    3
Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: A systematic review

Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: A systematic review
18    56    3
Disparities in oesophageal cancer risk by age, sex, and nativity in Kuwait:1980–2019

Disparities in oesophageal cancer risk by age, sex, and nativity in Kuwait:1980–2019
5    5    1
A phase 1 ‘window-of-opportunity’ trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

A phase 1 ‘window-of-opportunity’ trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
8    66    1